Member Info for jmfw

Think the problem lies with extent TLSA being shorted. Again, yesterday, just over 20% of total volume https://fintel.io/ss/us/tlsa. This seems to be a long established trend as witnessed https://www.nasdaq.com/market-activity/stocks/tlsa/short-interest. Seems to me this is the reason behind our sp not responding to good news. Might have to wait until the Foralumab news before we can shake off the shorters. Hope not.

Missed link: https://www.nasdaq.com/market-activity/stocks/tlsa/real-time

Lot of stuff on here. Not sure about volumes, but could, on a daily basis, provide trade details (similar london stock exchange site). 'Short Interest' tab interesting, which shows historic volumes.

Personally, comfortable with gentle upward momentum. If the sp grew by only 1% per day from 150p it would be 225p by mid November. I'd be very happy with that going into the promise of the inhaler date in December. Not suit traders, but for those in for a longer journey.........

Not sure whether or not covered/relevent....from rns dated 1 May "Further commercial details are not being disclosed but Avacta will receive a royalty on the sales of BAMS test kits by Adeptrix"

Interesting that again 'shorts' had 21% of the volume yesterday but the sp continued to climb. Much better we enjoy slow daily increments until end October, hopefully followed by positive inhaler news, which should set this alight.

Currently some 16%. However, surprised at the volume/% of 'short' trades recorded on the Nasdaq yesterday.
https://fintel.io/ss/us/tlsa

Looks to me the 'test' has not yet started, so at least another 2 weeks. He posted "The medical doctor in me is getting a sense of deja-vu again. Also in the news is the lack of COVID-19 testing. The next fortnight is going to be informative..." & then "We have completed site initiation visit for the UK lateral flow antigen testing study as part of #moonshot evaluation. Well run centres. @MFTnhs research nurse Anila is confident it’s unusual but @falcon_study is going to be a success!"

So.."next fortnight ..informative" & site visit for...antigen testing study"

No one on this bb can provide answers, only speculation. So lodge your interest and raise any issues you have:

A shareholder and investor webinar presentation by Alastair Smith, Chief Executive Officer, Tony Gardiner, Chief Financial Officer and Neil Bell, Chief Development Officer will take place at 10:30 hrs on Monday, 28 September 2020.

Maybe another false dawn, but currently +12%

The sp was some 22p at end of March, so pretty decent return since then. If you have the same patience as you had in GGP you'll be well rewarded.

extract from france24 link suggests it's an antibody test "This test is similar in ways to a pregnancy test. The colour of a saliva-soaked tablet will indicate whether or not virus antibodies are present without any need to go to a laboratory for analysis."

Was previously discussed on this bb.
https://seekingalpha.com/news/3593929-tlsa-falls-14-suggestions-spread-robinhood-traders-confused-tsla

Posts some 3-4 weeks ago alluded to the probabilty of mistaken identitity between Tiziana & Tesla which resulted in the very rapid rise. Could it be the same reasoning is behind the fall? Tesla has been the subject of significant shorting & their sp has taken a very big hit last 2 days. According to this link short interest in Tiziana is much reduced https://fintel.io/ss/us/tlsa

If we are part of this trial (which seems quite possible) would have thought it unlikely we'll get official news prior to the end date; more end September. We could get BAMS news very near future, & if it is as good as implied think the effect on the sp to be dramatic (infers, only, high s/s on the lft) due elevated expectations. Wonder if, as already discussed on this board, whether or not both devices are subject to NDAs, in which case news end September.

Lets hope we get something related to either soon, so the very tedious noise on here can be drowned out.

For those who think there is no 'shorting' in the sp, take a look at bottom of page: https://fintel.io/ss/us/tlsa

For me, breakout/breakdown 186/156. However, very much like avct, news driven, so unpredictable. For now seems comfortable in current zone, but news (or lack of it) will prove the driver.

emailing general/sales enquiries @ medusa19 for clarification, probably better.

150k @ 16:32

Agree with Spike, but also wonder if MMs taking shares for their back pockets knowing full well this could explode with further positive news.